|
CombinatoRx, Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile--Aarkstore Enterprise
CombinatoRx, Incorporated (CombinatoRx) is a biopharmaceutical company engaged in developing synergistic combinations pharmaceuticals. The company currently has a portfolio of products in the 2nd phase clinical trials associated with the treatment of rheumatoid arthritis, psoriasis, atopic dermatitis, Type-2 diabetes and asthma. The company is headquartered in Cambridge, United States
CombinatoRx, Incorporated - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
For more information please visit :
http://www.aarkstore.com/reports/CombinatoRx-Incorporated-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-20680.html
As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments.
[ Back To HealthTechZone.com's Homepage ]
|